Oramed Pharmaceuticals (ORMP) Return on Sales [ROS] (2016 - 2025)
Oramed Pharmaceuticals' Return on Sales [ROS] was -754.40% in Q4 2025, down 103.85 percentage points from the prior quarter.
Powered by 
Analysis
Oramed Pharmaceuticals (ORMP) Return on Sales [ROS] (2016 - 2025) Analysis & Trends
From Q2 2016 onward, Oramed Pharmaceuticals has reported Return on Sales [ROS] for 28 quarters.
- Return on Sales [ROS] shows a four-year change of +141.75 percentage points (FY2021 to FY2025).
- In earlier years, Return on Sales [ROS] was -1176.79% in FY2023 (+325.17 pp), -1501.96% in FY2022 and -896.15% in FY2021.
- The Q4 2025 figure marks the lowest quarterly Return on Sales [ROS] since Q4 2023.
- Per Business Quant data, ORMP's Return on Sales [ROS] in the three quarters before Q4 2025 was -650.55% (Q3 2025), -683.65% (Q2 2025) and -225.00% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Oramed Pharmaceuticals | 164.02 Mn | -170.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -754.40% |
| Sep 30, 2025 | -650.55% |
| Jun 30, 2025 | -683.65% |
| Mar 31, 2025 | -225.00% |
| Dec 31, 2023 | -1,176.79% |
| Sep 30, 2023 | -1,079.23% |
| Jun 30, 2023 | -562.46% |
| Mar 31, 2023 | -781.98% |
| Dec 31, 2022 | -1,363.50% |
| Sep 30, 2022 | -1,200.73% |
| Jun 30, 2022 | -1,693.92% |
| Mar 31, 2022 | -1,689.49% |
| May 31, 2021 | 898.38% |
| Feb 28, 2021 | 732.03% |
| Aug 31, 2020 | 443.02% |
| May 31, 2020 | 333.92% |
| Feb 29, 2020 | 598.96% |
| Nov 30, 2019 | -360.39% |
| Aug 31, 2019 | -344.35% |
| May 31, 2019 | -597.95% |
API Access
Oramed Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ORMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ORMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ORMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();